Item 1. Business
ITEM 1. BUSINESS
General
Acacia Research
Corporation (the “Company”, “we”, or “us”) acquires businesses and operating assets that we
believe to be undervalued and where we believe we can leverage our resources and skill sets to realize and unlock value. We leverage
our (i) access to flexible capital that can be deployed unconditionally, (ii) expertise in corporate governance and operational
restructuring, (iii) willingness to invest in out of favor industries and businesses that suffer from a complexity discount and
untangle complex, multi-factor situations, and (iv) expertise and relationships in certain sectors, to
complete strategic acquisitions of businesses, divisions, and/or assets with a focus on mature technology, healthcare, industrial
and certain financial segments. We seek to identify opportunities where we believe we are advantaged buyers, where we can avoid
structured sale processes and create the opportunity to purchase businesses, divisions and/or assets of companies at an attractive
price due to our unique capabilities, relationships, or expertise, or where we believe the target would be worth more to us than to
other buyers.
We operate our
business based on three key principles of People, Process and Performance and have built a management team with identified expertise
in Research, Execution and Operation of our targeted acquisitions.
We utilized these
skill sets and resources to acquire a portfolio of equity securities of life science businesses (the “Portfolio Companies”)
in June 2020. As of December 31, 2020, we have monetized a portion of the portfolio while retaining an interest in a number of operating
businesses, including a controlling interest in one of the companies in the portfolio. Further, some of the businesses in which we continue
to hold an interest generate revenues through the receipt of royalties.
1
We also operate
our legacy business of investing in intellectual property, or IP, and related absolute return assets and engaging in the licensing
and enforcement of patented technologies. We partner with inventors and patent owners, from small entities to large corporations,
applying our legal and technology expertise to patent assets to unlock the financial value in their patented inventions. We are
an intermediary in the patent marketplace, bridging the gap between invention and application, and facilitating efficiency in
connection with the monetization of patent assets.
We generate
revenues and related cash flows from the granting of IP rights for the use of patented technologies that our operating subsidiaries
control or own. We assist patent owners with the prosecution and development of their patent portfolios, the protection of their
patented inventions from unauthorized use, the generation of licensing revenue from users of their patented technologies and,
where necessary, with the enforcement against unauthorized users of their patented technologies through the filing of patent infringement
litigation. Currently, on a consolidated basis, our operating subsidiaries own or control the rights to multiple patent portfolios,
which include U.S. patents and certain foreign counterparts, covering technologies used in a variety of industries.
We have established
a proven track record of licensing and enforcement success with over 1,590 license agreements executed to date, across nearly
200 patent portfolio licensing and enforcement programs. To date, we have generated gross licensing revenue of over $1.6 billion,
and have returned more than $797 million to our patent partners.
For
further details of the development of our business, refer to our Annual Report on Form 10-K for the year ended December 31, 2019,
which is incorporated herein by reference.
Corporate Information
We were originally
incorporated in California in January 1993 and reincorporated in Delaware in December 1999. Our website address is www.acaciaresearch.com .
Reference in this annual report to this website address does not constitute incorporation by reference of the information contained
on or accessed through our website and references to our website address in this annual report are inactive textual references
only. We make our filings with the Securities and Exchange Commission, or the SEC, including our annual reports on Form 10-K,
quarterly reports on Form 10-Q, current reports on Form 8-K, other reports filed or furnished pursuant to Section 13(a) or 15(d)
of the Exchange Act, and amendments to the foregoing reports, available free of charge on or through our website as soon as reasonably
practicable after we file these reports with, or furnish such reports to, the SEC. In addition, we post the following information
on our website:
·
our code of conduct for chief
executive officer and other senior officers;
·
our code of conduct for employees
and directors and our fraud policy;
·
our insider trading policy; and
·
charters for our audit committee,
nominating and corporate governance committee and compensation committee.
Also, the SEC
maintains an Internet website that contains reports, proxy and information statements, and other information regarding issuers,
including us, that file electronically with the SEC. The public can obtain any documents that we file with the SEC at http://www.sec.gov .
2
Patent Licensing and Enforcement
Business
We are a principal in the licensing and enforcement
of patent portfolios, with our operating subsidiaries obtaining the rights in the patent portfolio, or purchasing the patent portfolio
outright. We assume all responsibility for advancing operational expenses while pursuing a patent licensing and enforcement program, and
when applicable, share net licensing revenue with our patent partners as that program matures, on a pre-arranged and negotiated basis.
We may also provide upfront capital to patent owners as an advance against future licensing revenue.
We have the flexibility to structure arrangements
to address the needs and specific sets of circumstances presented by each of our unique patent partners, ranging from outright purchases
to various forms of partnering arrangements.
Generally, we maintain a substantial preferred
rate of return until all deployed capital and advanced operational costs are recovered by us. After recovery of these costs, the net profit
revenue share with patent partner commences, if applicable.
We engage highly competent and experienced patent
lawyers to prosecute our patent portfolio litigation. It is imperative for us to be persistent and patient throughout the litigation process
as it typically takes 18-36 months from the filing date of a lawsuit to yield a license agreement from a potential licensee. Often, it
takes longer to secure a final court judgment.
Patent license negotiations and litigation initiated
by our operating subsidiaries usually lead to serious and thoughtful discussions with the unauthorized users of the patented inventions.
The result can be quite favorable with the user being granted rights under the patents for the patented invention in its products and
services in exchange for financial remuneration.
In fiscal year 2019 and 2020, the Company experienced
a number of changes in its outlook and leadership. With new management in place, the focus was on capturing the value of remaining portfolio
assets while building the new business pipeline. In addition, we began to pursue other business opportunities which complement our legacy
licensing and enforcement business and leverage our IP expertise.
Patented Technologies
Currently, on a consolidated basis, our operating
subsidiaries own or control the rights to patent portfolios covering technologies used in a number of industries, including: transportation
and automotive, telecommunications, semiconductor, consumer electronics, energy efficiency, wireless, video/imaging and medical devices.
Refer to Item 7. “Management’s Discussion
and Analysis of Financial Condition and Results of Operations” for a summary of patent portfolios generating revenues for the applicable
periods presented.
Competition
We face intense competition in identifying, evaluating
and executing strategic acquisitions from other entities having a business objective similar to ours, including private equity groups
and operating businesses seeking strategic acquisitions. We compete with financial firms, corporate buyers and others investing in strategic
opportunities and acquiring IP. Many of these competitors may have greater financial and human capital resources than we have. We may
find more companies entering the market for similar technology opportunities, which may reduce our market share in one or more technology
industries that we currently or in the future may rely upon to generate future revenue.
3
Employees
As of December
31, 2020, on a consolidated basis, we had 20 full-time employees. Neither we, nor any of our subsidiaries, are a party to any
collective bargaining agreement. We believe we have good relations with our employees.
Text extracted from the filing as submitted to EDGAR. Formatting, tables and exhibits are simplified for reading; the original document is authoritative for anything you rely on.